ECHA management board elects new deputy chairman
Martin Lynch takes the role
Lynch, from Ireland, will hold the role for the next two years. Dr Thomas Jakl, from Austria, is chairman.
You may also like
Ingredients
GELITA launches ultra-low endotoxin MEDELLAPRO grade targeting sensitive biomedical applications
The new gelatin excipient, featuring less than ten endotoxin units per gram, expands GELITA's ECE portfolio for drug delivery, vaccine stabilisation and 3D bioprinting, alongside recombinant animal-free collagen development
Manufacturing
NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain
NorthStar Medical Radioisotopes and QSA Global have announced a new strategic services agreement to support commercial-scale production of actinium-225 through a closed-loop radium-226 target supply and recycling programme for targeted alpha therapies
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge
A new Moody's report identifies four compounding risk factors driving pharmaceutical supply chain instability and warns that siloed risk management is leaving the sector dangerously exposed